Plasma renin activity-guided strategy for the management of hypertension

Area of Science:

• Cardiology
• Pharmacology
• Nephrology

Background:

• Hypertension remains uncontrolled in nearly 50% of patients, with increasing rates of resistant hypertension.
• Current guidelines and treatments are insufficient for a significant patient population.
• The American Heart Association recommends further research into pharmacologic strategies for resistant hypertension.

Purpose of the Study:

• To review the principles and historical development of plasma renin activity (PRA)-guided antihypertensive therapy.
• To explore alternative methods for classifying patient responses to hypertension medications.
• To present recent data supporting the efficacy of PRA-guided hypertension management.

Main Methods:

• Review of existing literature on plasma renin activity measurement and its application in hypertension management.
• Analysis of therapeutic strategies based on PRA levels (low PRA vs. high PRA).
• Discussion of alternative patient classification approaches for guiding antihypertensive drug selection.

Main Results:

• Low PRA suggests a need for natriuretic, volume-mediated therapies (e.g., diuretics, calcium channel blockers).
• High PRA indicates the potential benefit of antirenin system therapies (e.g., beta-blockers, ACE inhibitors, ARBs).
• Evidence supports PRA measurement as a tool to personalize hypertension treatment.

Conclusions:

• Plasma renin activity measurement offers a targeted approach to optimizing antihypertensive therapy.
• PRA-guided treatment selection can improve blood pressure control in patients with resistant or difficult-to-manage hypertension.
• This strategy holds promise for more effective management of cardiovascular and renal disease.